FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296797654> ?p ?o ?g. }

• W4296797654 endingPage "978" @default.
• W4296797654 startingPage "975" @default.
• W4296797654 abstract "The reason that immune checkpoint inhibitors have not been widely applied to pancreatic cancer treatment is probably because of low immunogenicity or dense stromal fibrosis. Recently, only pembrolizumab was recommended for DNA mismatch repair deficiency or high microsatellite instability by National Comprehensive Cancer Network guideline. Pancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of pancreatic cancer, with a poor overall survival rate, the value of immunotherapy for PDAC needs more research. Here, we report a 56-year-old man suffered from PDAC with liver metastasis after radical surgery. The next-generation sequencing result demonstrated that it had remarkably high tumor mutational burden (TMB) of 49.92 Muts/Mb and microsatellite stability. Sintilimab (anti-PD-1) monotherapy was continuously administrated after failure of combined chemotherapy in second line, achieving stable disease within 22 months and few immunotherapy-related adverse events. To our knowledge, this is the first time to report a good outcome achieving 22 months with progression-free survival after PDAC metastasis with monotherapy of sintilimab. TMB may serve as a potential efficacy-related predictor in PDAC patients with sintilimab and help physicians make optimum clinical strategy." @default.
• W4296797654 created "2022-09-24" @default.
• W4296797654 creator A5007203749 @default.
• W4296797654 creator A5018706042 @default.
• W4296797654 creator A5031693357 @default.
• W4296797654 creator A5044544424 @default.
• W4296797654 creator A5046899351 @default.
• W4296797654 creator A5053447705 @default.
• W4296797654 creator A5057026207 @default.
• W4296797654 creator A5065047387 @default.
• W4296797654 creator A5070934699 @default.
• W4296797654 creator A5089313511 @default.
• W4296797654 creator A5091194849 @default.
• W4296797654 date "2022-08-09" @default.
• W4296797654 modified "2023-10-01" @default.
• W4296797654 title "Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report" @default.
• W4296797654 cites W1790626605 @default.
• W4296797654 cites W2044363258 @default.
• W4296797654 cites W2104347254 @default.
• W4296797654 cites W2165480504 @default.
• W4296797654 cites W2514008771 @default.
• W4296797654 cites W2530516001 @default.
• W4296797654 cites W2683486796 @default.
• W4296797654 cites W2747101267 @default.
• W4296797654 cites W2907518765 @default.
• W4296797654 cites W2909679049 @default.
• W4296797654 cites W2916508569 @default.
• W4296797654 cites W2959096163 @default.
• W4296797654 cites W2967960429 @default.
• W4296797654 cites W2971653504 @default.
• W4296797654 cites W3005124847 @default.
• W4296797654 cites W3005976323 @default.
• W4296797654 cites W3016686675 @default.
• W4296797654 cites W3022265443 @default.
• W4296797654 cites W3049578108 @default.
• W4296797654 cites W3087717452 @default.
• W4296797654 cites W3128646645 @default.
• W4296797654 doi "https://doi.org/10.1097/cad.0000000000001334" @default.
• W4296797654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35946538" @default.
• W4296797654 hasPublicationYear "2022" @default.
• W4296797654 type Work @default.
• W4296797654 citedByCount "1" @default.
• W4296797654 countsByYear W42967976542022 @default.
• W4296797654 crossrefType "journal-article" @default.
• W4296797654 hasAuthorship W4296797654A5007203749 @default.
• W4296797654 hasAuthorship W4296797654A5018706042 @default.
• W4296797654 hasAuthorship W4296797654A5031693357 @default.
• W4296797654 hasAuthorship W4296797654A5044544424 @default.
• W4296797654 hasAuthorship W4296797654A5046899351 @default.
• W4296797654 hasAuthorship W4296797654A5053447705 @default.
• W4296797654 hasAuthorship W4296797654A5057026207 @default.
• W4296797654 hasAuthorship W4296797654A5065047387 @default.
• W4296797654 hasAuthorship W4296797654A5070934699 @default.
• W4296797654 hasAuthorship W4296797654A5089313511 @default.
• W4296797654 hasAuthorship W4296797654A5091194849 @default.
• W4296797654 hasBestOaLocation W42967976541 @default.
• W4296797654 hasConcept C104317684 @default.
• W4296797654 hasConcept C121608353 @default.
• W4296797654 hasConcept C126322002 @default.
• W4296797654 hasConcept C143998085 @default.
• W4296797654 hasConcept C180754005 @default.
• W4296797654 hasConcept C2777148230 @default.
• W4296797654 hasConcept C2777701055 @default.
• W4296797654 hasConcept C2779013556 @default.
• W4296797654 hasConcept C2779767149 @default.
• W4296797654 hasConcept C2780057760 @default.
• W4296797654 hasConcept C2780210213 @default.
• W4296797654 hasConcept C2780962732 @default.
• W4296797654 hasConcept C526805850 @default.
• W4296797654 hasConcept C55493867 @default.
• W4296797654 hasConcept C61320498 @default.
• W4296797654 hasConcept C71924100 @default.
• W4296797654 hasConcept C86803240 @default.
• W4296797654 hasConceptScore W4296797654C104317684 @default.
• W4296797654 hasConceptScore W4296797654C121608353 @default.
• W4296797654 hasConceptScore W4296797654C126322002 @default.
• W4296797654 hasConceptScore W4296797654C143998085 @default.
• W4296797654 hasConceptScore W4296797654C180754005 @default.
• W4296797654 hasConceptScore W4296797654C2777148230 @default.
• W4296797654 hasConceptScore W4296797654C2777701055 @default.
• W4296797654 hasConceptScore W4296797654C2779013556 @default.
• W4296797654 hasConceptScore W4296797654C2779767149 @default.
• W4296797654 hasConceptScore W4296797654C2780057760 @default.
• W4296797654 hasConceptScore W4296797654C2780210213 @default.
• W4296797654 hasConceptScore W4296797654C2780962732 @default.
• W4296797654 hasConceptScore W4296797654C526805850 @default.
• W4296797654 hasConceptScore W4296797654C55493867 @default.
• W4296797654 hasConceptScore W4296797654C61320498 @default.
• W4296797654 hasConceptScore W4296797654C71924100 @default.
• W4296797654 hasConceptScore W4296797654C86803240 @default.
• W4296797654 hasIssue "9" @default.
• W4296797654 hasLocation W42967976541 @default.
• W4296797654 hasLocation W42967976542 @default.
• W4296797654 hasLocation W42967976543 @default.
• W4296797654 hasLocation W42967976544 @default.
• W4296797654 hasOpenAccess W4296797654 @default.
• W4296797654 hasPrimaryLocation W42967976541 @default.
• W4296797654 hasRelatedWork W2920863623 @default.

• next